-+ 0.00%
-+ 0.00%
-+ 0.00%

Indian High Growth Stocks With Insider Ownership Worth A Closer Look

Simply Wall St·08/06/2026 16:25:43
Listen to the news

US services and private sector growth stayed robust in July, which keeps attention on companies that can grow through a mixed backdrop. Fast growing stocks with high insider ownership stand out because their management teams are financially aligned with that growth story. This article highlights three stocks from the Fast Growing Stocks With High Insider Ownership screener that merit a closer look.

The stocks covered below are only a starting sample. The full screen surfaced 106 more companies with similarly compelling growth and insider ownership stories that are not included here. To identify and analyze the highest conviction ideas that fit your own criteria, go straight to the Fast Growing Stocks With High Insider Ownership screener.

Rubicon Research (NSEI:RUBICON)

Rubicon Research is a Mumbai based specialty pharmaceutical company that designs drug delivery systems such as sustained release liquids and gastro retentive formulations for areas including pain management, cardiovascular and central nervous system treatments. It currently generates about ₹17.5b in revenue from pharmaceutical products including generics, specialty drugs, APIs and related services. The stock has a market cap of roughly ₹253.8b.

Rubicon Research combines rapid earnings growth with a focused drug delivery niche and a strong footprint in the US market, which accounted for almost all of its recent revenue. Profit margins have widened and full year revenue of about ₹17.6b with net income of ₹2.5b indicates a business that is scaling rather than just expanding its top line. At the same time, a very high P/E ratio and reliance on external borrowing introduce valuation and funding risks that warrant attention. In addition, a relatively new board, high director turnover and elevated share price volatility mean that strong fundamentals sit alongside governance and risk questions that may merit closer review.

Rubicon Research is increasing earnings on a tightly focused, US-led portfolio, yet the high P/E ratio, recently appointed board, and reliance on debt leave key questions open. Get the full context in the analysis report for Rubicon Research

NSEI:RUBICON P/E Ratio as at Aug 2026
NSEI:RUBICON P/E Ratio as at Aug 2026

Build your own high growth and insider backed shortlist

Rubicon Research and the two other stocks in this article all surfaced from a single Simply Wall St screener, but the real opportunity is in building a filter set that fits the way you invest. Use our Screener to combine growth, valuation, balance sheet and risk checks into your own pipeline, or lean on the foundations of our curated Investing Ideas.

Privi Speciality Chemicals (BSE:530117)

Privi Speciality Chemicals is a Mumbai based aroma and fragrance ingredients producer that supplies key molecules used in home care, personal care and fine fragrances to leading FMCG companies in India and overseas. The business currently reports about ₹26.7b in revenue from its Aromatic Chemicals segment, highlighting how focused it is on this niche. The stock has a market cap of roughly ₹142.4b, which puts Privi Speciality Chemicals firmly in mid cap territory for Indian investors.

Privi Speciality Chemicals sits at the intersection of rising fragrance demand and a tightly focused specialty portfolio, with earnings of ₹3.3b in FY 2026, net margins of 13.1% and return on equity around 23.7%. Capacity is being lifted from roughly 48,000 tonnes to 54,000 tonnes and the product mix is shifting toward higher value molecules, while state incentive income and an annual dividend of ₹10 per share add another layer to the story. The trade off is a rich valuation relative to peers and a balance sheet that leans heavily on debt funding, so the key question is whether growth, margins and incentives can justify that pricing over the next few years.

Privi Speciality Chemicals blends focused aroma chemistry with mid cap scale and a rich valuation that many investors may be glossing over. Get the fuller picture in the analysis report for Privi Speciality Chemicals, including what that debt heavy balance sheet could really mean for the story ahead.

BSE:530117 P/E Ratio as at Aug 2026
BSE:530117 P/E Ratio as at Aug 2026

Bajel Projects (NSEI:BAJEL)

Bajel Projects is an EPC contractor focused on power transmission and distribution, handling everything from engineering and design to manufacturing, construction and commissioning of extra high voltage lines, substations, monopoles and tubular structures. The company generated about ₹27.9b in revenue from Power Transmission and Power Distribution, showing how concentrated it is in this core segment, with India contributing the vast majority of revenue. The stock has a market cap of roughly ₹21.3b, putting Bajel Projects in the smaller listed infrastructure players bracket.

Bajel Projects operates at the intersection of power infrastructure investment and an order pipeline that now includes ultra large EPC wins in India and across the MENA region. Forecasts in available research indicate growth in earnings and revenue, yet profit margins remain thin and the balance sheet relies entirely on external borrowing, which raises questions about how much turbulence the business can absorb. The stock trades on a very high earnings multiple relative to sector averages and recent share price performance has lagged peers, so investors are being asked to pay for potential future delivery rather than current profitability. For anyone tracking higher growth stocks backed by insiders, the key issue is whether those newer contracts and a relatively young management bench can convert that valuation premium into lasting value.

Bajel Projects sits at the crossroads of ambitious power grid build outs and a thin-margin, debt-funded balance sheet that many investors might be underestimating. Get the full story in the Bajel Projects financial health report

NSEI:BAJEL P/E Ratio as at Aug 2026
NSEI:BAJEL P/E Ratio as at Aug 2026

Seeking Alternatives Before The Crowd Moves

Fresh ideas can gain breakout momentum quickly, and early movers sometimes find opportunities while they are still under the radar. Consider researching them before they become widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.